The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

The Amsler grid is a simple and effective tool often used to detect early signs of macular degeneration. This is a grid of ...

Izervay (avacincaptad pegol) is a prescription injection used to treat severe age-related macular degeneration (AMD ... side effects during Izervay treatment. Examples of the drug’s commonly ...

University of California San Diego researchers have identified a U-shaped association between high-density lipoprotein (HDL) ...

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

Health scientists from the University of Virginia have found a previously unknown contributor to harmful blood vessel growth ...

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy ...

Millions of people across the world suffer from dry and wet macular degeneration. Unfortunately, there’s no cure for it, ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

On completion of the scans and tests, he said: “You have early age-related macular degeneration ... the sound of a voice to recognise who was there.